Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest method for percutaneous intervention, particularly in terms of access-related complications and mortality. Thanks to these advantages, the transradial approach has expanded to non-coronary territories, such as the carotid and peripheral.

However, it entails challenges such as radial spasm, and radial artery occlusion (RAO) following procedure, which occurs in approximately 9% of cases. The distal radial approach (DRA) has evolved from salvage option for RAO recanalization to preferred access site for transradial procedures, with low occlusion rate due to its excellent anastomotic network.

Objective: Comparative Study of Radial Artery Occlusion between Distal and Traditional Radial Access

The aim of TENDERA (Traditional Entry Point vs. Distal Puncture of Radial Artery), was to compare RAO incidence between DRA and TRA at one-year follow-up. Study operators were required to have experienced at least 100 DRA procedures.

Patients with acute or chronic coronary syndromes (excluding STEMI) were recruited from seven clinical centers in Russia. Those with a history of radial artery interventions, coagulopathies, or ≤1.5 mm radial artery diameter were excluded. Hydrophilic‐coated introducer sheaths (Terumo, Merit, or Lepu Medical) up to 16 cm in length were used for coronary procedures, and access was evaluated prior procedure via ultrasound.

The primary endpoint was Doppler assessed RAO presence. Radial patency was also measured after procedure, at 24 hours and 1, 6, and 12 months. Secondary endpoints included puncture time, time to obtain access, radiation dose (Kerma), major bleeding, and other access-related complications such as hematomas, compartment syndrome, pseudoaneurysm, or fistulas.

Read also: Asymptomatic Aortic Stenosis: A Complex Decision.

In total, 795 patients were included, mean age 63, 66% men. Average wrist circumference was 19.1±2 cm, and 14% of cases were ACS clinical presentations. Mean radial artery diameter was 2.6 mm for the conventional access and 2.27 mm for distal, and 6Fr inductors (82.1%) were mostly used.

Results

RAO incidence resulted 6.7% for the conventional access vs 2.5% for distal (RR 2.59 [CI 95%: 1.29–5.59], p = 0.010). Vascular anomalies were reported in 10.8% of cases, transradial loop being the most common (6.2%). Radial spasm incidence was similar between the groups (23.9% in TRA vs. 23.6% in DRA). However, DRA patients presented higher crossover rate (4.6% vs. 1%, p = 0.013).

Independent RAO predictors included traditional transradial access (OR = 2.59 [CI 95%: 1.29–5.59], p = 0.01), radial/inductor index <1.1:1 (OR = 0.21 [CI 95%: 0.04–0.92], p = 0.048) and female sex (OR = 3.94 [CI 95%: 1.82–8.86], p < 0.001).

Read also: TAVI and Aortic Regurgitation: Are All Valves the Same?

There were no significant differences in total procedural time (20 min [IQR: 8.0–35.0] vs. 20 min [IQR: 10.0–35.0], p = 0.315) or radiation dose (996.9 mGy [IQR: 554.1–1839.1] vs. 924.5 mGy [IQR: 493.1–1709.5], p = 0.238). TRA had a higher incidence of hematomas (27.0% vs. 9.0%, p < 0.001), while only one patient presented pseudoaneurysm.

Conclusions

The TENDERA showed that, with protocolled management, the distal radial access presented a significantly lower incidence of radial occlusion, both in the acute (thrombosis) and late periods (poor vascular remodeling).  

Original Title: Traditional Versus Distal Radial Access for Coronary Diagnostic and Revascularization Procedures: Final Results of the TENDERA Multicenter, Randomized Controlled Study.

Reference: Babunashvili AM, Pancholy S, Zulkarnaev AB, Kaledin AL, Kochanov IN, Korotkih AV, Kartashov DS, Babunashvili MA. Traditional Versus Distal Radial Access for Coronary Diagnostic and Revascularization Procedures: Final Results of the TENDERA Multicenter, Randomized Controlled Study. Catheter Cardiovasc Interv. 2024 Dec;104(7):1396-1405. doi: 10.1002/ccd.31271. Epub 2024 Oct 30. PMID: 39474765; PMCID: PMC11667409.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...